Page last updated: 2024-08-21

adamantane and Rhabdomyosarcoma

adamantane has been researched along with Rhabdomyosarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Basma, H; Darwiche, N; Dweik, L; El-Eit, R; Ghamloush, F; Ghayad, SE; Harajly, M; Mancinelli, A; Pisano, C; Rabeh, W; Rammal, G; Saab, R; Zalzali, H	1

Other Studies

1 other study(ies) available for adamantane and Rhabdomyosarcoma

Article	Year
The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma. International journal of cancer, 2016, Mar-15, Volume: 138, Issue:6 Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Survival; Cinnamates; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Heterografts; Humans; Mice; Oncogene Proteins, Fusion; Rhabdomyosarcoma; S Phase Cell Cycle Checkpoints; Signal Transduction; Tumor Suppressor Protein p53	2016

Article

Year

The synthetic retinoid ST1926 as a novel therapeutic agent in rhabdomyosarcoma.

International journal of cancer, 2016, Mar-15, Volume: 138, Issue:6

Topics: Adamantane; Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Cell Survival; Cinnamates; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Heterografts; Humans; Mice; Oncogene Proteins, Fusion; Rhabdomyosarcoma; S Phase Cell Cycle Checkpoints; Signal Transduction; Tumor Suppressor Protein p53

2016